<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01407159</url>
  </required_header>
  <id_info>
    <org_study_id>ASSIST</org_study_id>
    <nct_id>NCT01407159</nct_id>
  </id_info>
  <brief_title>A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting</brief_title>
  <acronym>ASSIST</acronym>
  <official_title>ASSIST - A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>JOTEC GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>JOTEC GmbH</source>
  <brief_summary>
    <textblock>
      Cohort study according to national regulatory guidelines: Non-interventional, observational
      cohort study. Pair-matched comparison with patients chosen from historical series.

      To evaluate the clinical and technical success as well as the safety and feasibility of the
      E-XL aortic stent used in complicated type B aortic dissection in addition to a classic
      stentgraft in a single procedure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the clinical and technical success as well as the safety and feasibility of the E-XL aortic stent used in complicated type B aortic dissection in addition to a classic thoracic stent-graft in a single procedure.</measure>
    <time_frame>February 2014</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Type B Aortic Dissection</condition>
  <arm_group>
    <arm_group_label>Thoracic Stentgraft plus E-XL</arm_group_label>
    <description>male and female patients with complicated type B aortic dissection involving the infra-diaphragmatic aorta treated with any thoracic stentgraft extended by the E-XL aortic stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>historical control group fulfilling the following criteria:
Age +/- 3 years
Sex matched
Same follow-up period</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Male and female patients with complicated type B aortic dissection involving the
        infra-diaphragmatic aorta
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        The clinical records of the patients mus support the following criteria:

          -  Age &gt; 18 years

          -  Type B dissection with expanding false lumen eligible for endovascular treatment which
             occured within 90 days prior to implantation

          -  The endovascular treatment may be associated with a complementary surgical operation

          -  The total diameter of the dissected aortic segment should not surpass 6cm, and have
             increased between 0.5 and 1cm within 1 month, prior to implantation

          -  Visceral arteries involvement, i.e. perfusion of side branches via true or false lumen
             of type B dissection

          -  Aortic kinking &lt; 90°

          -  The patient must be available for the appropriate follow-up times for the duration of
             the study

          -  Informed consent from patient or authorized relative

        The data of whose patients clinical records confirm one of the following conditions will
        not be considered in this study:

          -  Patients with a contraindication as indicated in the instruction for use

          -  Patients with chronic thrombocytopenia or ongoing anticoagulation

          -  Patients with renal failure and/or creatinine &gt;2.4mg/dl immediately before the
             intervention

          -  Patients in whom the false lumen is completely thrombosed

          -  Patients with ongoing infection

          -  Patients with ongoing cancer

          -  Patients who are enrolled in a clinical study

          -  Aortic landing zone diameter over 40 mm

          -  Potentially emboligenic iliac and aortic atheroma lesions

          -  Associated pathology with life expectancy of less than 24 months

          -  Unstable infectious syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>German Heart Center</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hannover Medical School</name>
      <address>
        <city>Hanover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Jena</city>
        <zip>07747</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Franziskus Hospital</name>
      <address>
        <city>Muenster</city>
        <zip>48145</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Munich Grosshadern</name>
      <address>
        <city>Munich</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Rostock</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Department of Radiologia Toracica e Vascolare</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Policlinico San Donato Milano</name>
      <address>
        <city>Milan</city>
        <zip>20097</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krakowski Szpital Specjalistyczny im. Jana Pawła II</name>
      <address>
        <city>Kraków</city>
        <zip>31-202</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Samodzielny Publiczny Szpital Kliniczny Nr 1</name>
      <address>
        <city>Lublin</city>
        <zip>20-081</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thorax Insitute, Hospital Clinic, University of Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Clinico Universitario de Valladolid</name>
      <address>
        <city>Valladolid</city>
        <zip>47005</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
    <country>Poland</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2011</study_first_submitted>
  <study_first_submitted_qc>August 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 2, 2011</study_first_posted>
  <last_update_submitted>April 25, 2014</last_update_submitted>
  <last_update_submitted_qc>April 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>type b dissection</keyword>
  <keyword>thoracic stentgraft</keyword>
  <keyword>aortic stent</keyword>
  <keyword>clinical and technical success</keyword>
  <keyword>safety and feasibility of E-XL aortic stent</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

